P01CA288662

Tipping points in cancer - A new program project on tipping points in cancer will address fundamental questions about processes in cancer initiation and progression.

The premise of the program is that cancer develops through a series of stochastic steps, some of which are non-genetic (i.e., not mutational), including steps that are non-cell-autonomous (i.e., collective).

Three team-oriented research projects will investigate cell states and cell-cell interactions that drive such transitions and explore their impact on cancer prevention and therapy.

Each project deals with a cancer that, when modeled using genetically engineered mice, points to the existence of unexplained thresholds in the transition between pre-malignant and malignant states.

One project will leverage an improved mouse model of chronic myeloid leukemia (CML), which suggests that stochastic, non-genetic transitions are essential in leukemogenesis.

The model will be used to investigate the origins of primary therapeutic resistance and the means by which existing therapies may be improved.

A second project will investigate the origins of melanoma, using mouse models to clarify the many cellular states that have been distinguished in this cancer and elucidate relationships between such states and accumulated mutations, arrangements of cells in space, and the microenvironment.

The third project will leverage mouse models of BRCA1-driven, triple-negative breast cancer, wherein observations suggest the existence of a distinct pre-malignant state, seeking to identify the signals and cell-cell interactions that create and maintain this state, and elucidate the events that allow rare escape to malignancy.

All three projects combine mathematical modeling, genomics, and computational biology.

All three will be served by a shared resource core for analyzing single cell data and providing access to new and emerging technologies and algorithms.

An administrative core and an external scientific advisory board will assist with management, integration, and evaluation of program activities.

Irvine University Of California

TO PROVIDE FUNDAMENTAL INFORMATION ON THE CAUSE AND NATURE OF CANCER IN PEOPLE, WITH THE EXPECTATION THAT THIS WILL RESULT IN BETTER METHODS OF PREVENTION, DETECTION AND DIAGNOSIS, AND TREATMENT OF NEOPLASTIC DISEASES. CANCER BIOLOGY RESEARCH INCLUDES THE FOLLOWING RESEARCH PROGRAMS: CANCER CELL BIOLOGY; CANCER IMMUNOLOGY, HEMATOLOGY AND ETIOLOGY; DNA AND CHROMOSOMAL ABERRATIONS; TUMOR BIOLOGY AND METASTASIS; AND STRUCTURAL BIOLOGY AND MOLECULAR APPLICATIONS.

93.396 - Cancer Biology Research

National Cancer Institute (NCI) [HHS - NIH]

Irvine, California 926970001 United States

Single Zip Code

National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) (PAR-23-059)

Amendment Since initial award the total obligations have increased 97% from $2,186,372 to $4,300,055.